Zhou Guangchang, Khan Faraz, Dai Qing, Sylvester Juliesta E, Kron Stephen J
Department of Molecular Genetics and Cell Biology, Gordon Center for Integrative Sciences, W522A, The University of Chicago, Chicago, IL 60637, USA.
Mol Biosyst. 2012 Sep;8(9):2395-404. doi: 10.1039/c2mb25163a. Epub 2012 Jul 6.
Robust methods for highly parallel, quantitative analysis of cellular protein tyrosine kinase activities may provide tools critically needed to decipher oncogenic signaling, discover new targeted drugs, diagnose cancer and monitor patients. Here, we describe proof-of-principle for a novel protein kinase assay with the potential to help overcome these challenges. MALDI-TOF mass spectrometry provides an ideal tool for label-free multiplexed analysis of peptide phosphorylation, but is poorly matched to homogeneous assays and complex samples. Thus, we conjugated a common oligonucleotide tag to multiple peptide substrates, offering efficient capture from solution-phase kinase reactions by annealing to the complementary sequence tethered to PEG-passivated superparamagnetic microparticles. To enable reversible conjugation, we developed a novel bifunctional cross-linker allowing simple and efficient preparation of photocleavable peptide-oligonucleotide conjugates. After washing away contaminants and following photorelease, MALDI-TOF analysis yielded relative phosphorylation of each peptide with high sensitivity and specificity. Validating the hybridization-mediated multiplexed kinase assay, when three peptide substrate-oligonucleotide conjugates were mixed with the tyrosine kinase c-Abl and ATP, we readily observed their differential phosphorylation yet measured a common IC(50) for the Abl kinase inhibitor imatinib. This new assay enables analysis of protein kinase activities in a multiplexed format amenable to screening inhibitors against multiple kinases in parallel, an important capability for drug discovery and predictive diagnostics.
用于细胞蛋白酪氨酸激酶活性高度平行定量分析的稳健方法,可能提供破解致癌信号、发现新靶向药物、诊断癌症和监测患者所需的关键工具。在此,我们描述了一种新型蛋白激酶测定法的原理证明,该方法有潜力帮助克服这些挑战。基质辅助激光解吸电离飞行时间质谱(MALDI-TOF质谱)为肽磷酸化的无标记多重分析提供了理想工具,但与均相测定和复杂样品不太匹配。因此,我们将一种常见的寡核苷酸标签与多个肽底物偶联,通过与连接到聚乙二醇(PEG)钝化超顺磁性微粒上的互补序列退火,实现从溶液相激酶反应中高效捕获。为实现可逆偶联,我们开发了一种新型双功能交联剂,可简单高效地制备光可裂解的肽-寡核苷酸偶联物。洗去污染物并进行光释放后,MALDI-TOF分析以高灵敏度和特异性产生了每个肽的相对磷酸化。在验证杂交介导的多重激酶测定时,当将三种肽底物-寡核苷酸偶联物与酪氨酸激酶c-Abl和ATP混合时,我们很容易观察到它们的差异磷酸化,但测得Abl激酶抑制剂伊马替尼的共同半数抑制浓度(IC50)。这种新测定法能够以适合同时筛选针对多种激酶的抑制剂的多重形式分析蛋白激酶活性,这是药物发现和预测诊断的一项重要能力。